Livedoid vasculopathy associated with combined prothrombin G20210A and factor V (Leiden) heterozygosity and MTHFR C677T homozygosity
- PMID: 18360788
- DOI: 10.1007/s11239-008-0214-1
Livedoid vasculopathy associated with combined prothrombin G20210A and factor V (Leiden) heterozygosity and MTHFR C677T homozygosity
Abstract
Livedoid vasculopathy (LV) is an occlusive thrombotic disease of lower extremities. A 34-year-old woman presented with 4-year history of recurrent necrotic and painful lesions with violaceous and purpuric border on both legs. Initial treatment with hydroxychloroquine, dapsone and prednisone were unsuccessful. Skin biopsy showed inflammatory infiltrate with epidermal necrosis. Prothrombin G20210A and factor V-Leiden heterozygosity, and MTHFR C677T homozygosity with hyperhomocysteinemia were confirmed. LV diagnosis was made; acetylsalicylic acid, folic acid, vitamin B12, and prednisone treatement resulted in complete healing. This is the first report on coexistence of prothrombin G20210A, factor V-Leiden, and homozygous MTHFR C677T with hyperhomocysteinemia in LV.
Similar articles
-
Factor V Leiden G1691A, prothrombin G20210A, and MTHFR C677T mutations in Turkish inflammatory bowel disease patients.Hepatogastroenterology. 2007 Jul-Aug;54(77):1438-42. Hepatogastroenterology. 2007. PMID: 17708272
-
Livedoid vasculopathy associated with plasminogen activator inhibitor-1 promoter homozygosity (4G/4G) and prothrombin G20210A heterozygosity: response to t-PA therapy.Acta Derm Venereol. 2010;90(1):91-2. doi: 10.2340/00015555-0760. Acta Derm Venereol. 2010. PMID: 20107738 No abstract available.
-
Factor V G1691A, prothrombin G20210A, and methylenetetrahydrofolate reductase [MTHFR] C677T gene polymorphism in angiographically documented coronary artery disease.J Thromb Thrombolysis. 2004 Jun;17(3):199-205. doi: 10.1023/B:THRO.0000040489.86029.27. J Thromb Thrombolysis. 2004. PMID: 15353918
-
Contraception-related deep venous thrombosis and pulmonary embolism in a 17-Year-old girl heterozygous for factor V leiden, prothrombin G20210A mutation, MTHFR C677T and homozygous for PAI-1 mutation: report of a family with multiple genetic risk factors and review of the literature.Pathophysiol Haemost Thromb. 2010;37(1):24-9. doi: 10.1159/000319051. Epub 2010 Jul 20. Pathophysiol Haemost Thromb. 2010. PMID: 20664190 Review.
-
Association between factor V Leiden, prothrombin G20210A, and methylenetetrahydrofolate reductase C677T mutations and events of the arterial circulatory system: a meta-analysis of published studies.Am Heart J. 2003 Dec;146(6):948-57. doi: 10.1016/S0002-8703(03)00519-2. Am Heart J. 2003. PMID: 14660985 Review.
Cited by
-
Livedoid vasculopathy and its association with genetic variants: A systematic review.Int Wound J. 2021 Oct;18(5):616-625. doi: 10.1111/iwj.13563. Epub 2021 Mar 8. Int Wound J. 2021. PMID: 33686673 Free PMC article.
-
Refractory ulcerations associated with livedoid vasculopathy successfully treated with tofacitinib.Dermatol Ther. 2020 Nov;33(6):e14470. doi: 10.1111/dth.14470. Epub 2020 Nov 16. Dermatol Ther. 2020. PMID: 33112475 Free PMC article. No abstract available.
-
A Refractory Livedoid Vasculopathy Accompanied by Methylene Tetrahydrofolate Reductase Gene Polymorphism Successfully Treated with Hyperbaric Oxygen Therapy.Ann Dermatol. 2023 May;35(Suppl 1):S59-S62. doi: 10.5021/ad.20.330. Ann Dermatol. 2023. PMID: 37853867 Free PMC article.
-
Painless Livedoid Vasculopathy in a Patient with G20210A Prothrombin Gene Mutation.Case Rep Med. 2012;2012:910231. doi: 10.1155/2012/910231. Epub 2012 Sep 5. Case Rep Med. 2012. PMID: 22988463 Free PMC article.
-
Livedoid vasculopathy in a patient with lupus anticoagulant and MTHFR mutation: treatment with low-molecular-weight heparin.J Thromb Thrombolysis. 2012 Nov;34(4):541-4. doi: 10.1007/s11239-012-0743-5. J Thromb Thrombolysis. 2012. PMID: 22592843
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources